WallStSmart
CDNA

CareDx Inc

NASDAQ: CDNA · HEALTHCARE · DIAGNOSTICS & RESEARCH

$20.81
+0.05% today

Updated 2026-04-30

Market cap
$1.09B
P/E ratio
P/S ratio
2.86x
EPS (TTM)
$-0.40
Dividend yield
52W range
$11 – $23
Volume
0.7M

CareDx Inc (CDNA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+187.2%
Last 4 quarters
Revenue YoY growth
+39.0%
Most recent quarter
EPS YoY growth
+240.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+6.8%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+11.9%
2025-11-04
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-31$0.34+161.5%$16.43$17.87+8.8%
2026-03-04$0.12+1300.0%$18.80$18.75-0.3%
2025-11-04$0.28+450.0%$14.77$16.53+11.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$0.13$0.34+161.5%$117.70M+39.0%
2025-12-31$-0.01$0.12+1300.0%$108.39M+25.2%
2025-09-30$-0.08$0.28+450.0%$100.06M+20.7%
2025-06-30$-0.10$0.10+200.0%$86.68M-6.1%
2025-03-31$0.07$0.10+46.4%$84.69M+17.5%
2024-12-31$0.15$0.18+22.0%$86.58M+32.0%
2024-09-30$0.01$0.14+1300.0%$82.88M+23.4%
2024-06-30$-0.14$0.25+278.6%$92.27M+31.3%
2024-03-31$-0.21$-0.03+85.7%$72.05M
2023-12-31$-0.27$-0.17+37.0%$65.57M
2023-09-30$-0.40$-0.18+55.0%$67.19M
2023-06-30$-0.31$-0.18+41.9%$70.30M

Frequently asked questions

Has CareDx Inc beaten earnings estimates?
CareDx Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +187.2% over the last 3 quarters.
How does CDNA stock react to earnings?
CDNA stock has moved an average of +6.8% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is CareDx Inc's revenue growth rate?
CareDx Inc reported year-over-year revenue growth of +39.0% in its most recent quarter, with EPS growing +240.0% year-over-year.